{"id":"https://openalex.org/W4400325673","doi":"https://doi.org/10.1007/s12325-024-02926-6","title":"Effect of Hepatic Impairment on Trofinetide Exposures Using an In Silico Physiologically Based Pharmacokinetic Model","display_name":"Effect of Hepatic Impairment on Trofinetide Exposures Using an In Silico Physiologically Based Pharmacokinetic Model","publication_year":2024,"publication_date":"2024-07-04","ids":{"openalex":"https://openalex.org/W4400325673","doi":"https://doi.org/10.1007/s12325-024-02926-6","pmid":"https://pubmed.ncbi.nlm.nih.gov/38963587","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11263405"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-024-02926-6","doi":"https://doi.org/10.1007/s12325-024-02926-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-024-02926-6","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1007/s12325-024-02926-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083756495","display_name":"Mona Darwish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mona Darwish","raw_affiliation_strings":["Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA. mdarwish@acadia-pharm.com","Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA. mdarwish@acadia-pharm.com","institution_ids":["https://openalex.org/I125377440"]},{"raw_affiliation_string":"Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063254697","display_name":"Obinna N. Obianom","orcid":"https://orcid.org/0000-0002-2957-6615","observed_orcids":["https://orcid.org/0000-0002-2957-6615"]},"institutions":[{"id":"https://openalex.org/I867333293","display_name":"Simulations Plus (United States)","ror":"https://ror.org/02p0yhm49","country_code":"US","type":"company","lineage":["https://openalex.org/I867333293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Obinna N. Obianom","raw_affiliation_strings":["Simulations Plus Inc., Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simulations Plus Inc., Buffalo, NY, USA","institution_ids":["https://openalex.org/I867333293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087611468","display_name":"James M. Youakim","orcid":"https://orcid.org/0000-0001-5551-8956","observed_orcids":["https://orcid.org/0000-0001-5551-8956"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Youakim","raw_affiliation_strings":["Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030388037","display_name":"Inger M. Darling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867333293","display_name":"Simulations Plus (United States)","ror":"https://ror.org/02p0yhm49","country_code":"US","type":"company","lineage":["https://openalex.org/I867333293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Inger Darling","raw_affiliation_strings":["Simulations Plus Inc., Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simulations Plus Inc., Buffalo, NY, USA","institution_ids":["https://openalex.org/I867333293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006584044","display_name":"Viera Luk\u00e1\u010dov\u00e1","orcid":"https://orcid.org/0009-0004-4197-4570","observed_orcids":["https://orcid.org/0009-0004-4197-4570"]},"institutions":[{"id":"https://openalex.org/I867333293","display_name":"Simulations Plus (United States)","ror":"https://ror.org/02p0yhm49","country_code":"US","type":"company","lineage":["https://openalex.org/I867333293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viera Lukacova","raw_affiliation_strings":["Simulations Plus, Inc., Lancaster, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simulations Plus, Inc., Lancaster, CA, USA","institution_ids":["https://openalex.org/I867333293"]}]},{"author_position":"last","author":{"id":null,"display_name":"Heather Bradley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Bradley","raw_affiliation_strings":["Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130, USA","institution_ids":["https://openalex.org/I125377440"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5083756495"],"corresponding_institution_ids":["https://openalex.org/I125377440"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":1.4447,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.79884692,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"41","issue":"8","first_page":"3328","last_page":"3341"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.8169000148773193,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.8169000148773193,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.11819999665021896,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11772","display_name":"Genetics and Neurodevelopmental Disorders","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trofinetide","display_name":"trofinetide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.9279999732971191},{"id":"https://openalex.org/keywords/rett-syndrome","display_name":"Rett syndrome","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7960000038146973},{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.878000020980835},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.6000000238418579},{"id":"https://openalex.org/keywords/hematocrit","display_name":"hematocrit","score":0.7699999809265137},{"id":"https://openalex.org/keywords/child-pugh-score","display_name":"Child-Pugh score","score":0.7620000243186951},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.7760000228881836},{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.5659999847412109},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4059999883174896},{"id":"https://openalex.org/keywords/virtual-patients","display_name":"virtual patients","score":0.5740000009536743},{"id":"https://openalex.org/keywords/stochastic-simulation","display_name":"stochastic simulation","score":0.5849999785423279},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.550000011920929},{"id":"https://openalex.org/keywords/whole-blood-concentration","display_name":"whole blood concentration","score":0.8970000147819519},{"id":"https://openalex.org/keywords/red-blood-cell-binding","display_name":"red blood cell binding","score":0.5920000076293945},{"id":"https://openalex.org/keywords/oral-dose","display_name":"oral dose","score":0.367000013589859},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.80946284532547},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6285893321037292},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.523313045501709},{"id":"https://openalex.org/C2780959883","wikidata":"https://www.wikidata.org/wiki/Q111146","display_name":"Hematocrit","level":2,"score":0.5142359137535095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.493491530418396},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4826693832874298},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.45019060373306274},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3227577805519104},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.3222014307975769},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30071592330932617},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s12325-024-02926-6","doi":"https://doi.org/10.1007/s12325-024-02926-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-024-02926-6","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11263405","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11263405","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11263405/pdf/12325_2024_Article_2926.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"},{"id":"pmid:38963587","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38963587","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12325-024-02926-6","doi":"https://doi.org/10.1007/s12325-024-02926-6","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-024-02926-6","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315029","display_name":"ACADIA Pharmaceuticals","ror":"https://ror.org/030bhbq32"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400325673.pdf","grobid_xml":"https://content.openalex.org/works/W4400325673.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W3811691","https://openalex.org/W1559742681","https://openalex.org/W1817480084","https://openalex.org/W1961777655","https://openalex.org/W1967922110","https://openalex.org/W1987882040","https://openalex.org/W2009858196","https://openalex.org/W2027347753","https://openalex.org/W2045042214","https://openalex.org/W2059412778","https://openalex.org/W2059836653","https://openalex.org/W2060123467","https://openalex.org/W2062943711","https://openalex.org/W2064897206","https://openalex.org/W2075594879","https://openalex.org/W2095810566","https://openalex.org/W2103310685","https://openalex.org/W2164502083","https://openalex.org/W2582534361","https://openalex.org/W2615388266","https://openalex.org/W2787504356","https://openalex.org/W2905578307","https://openalex.org/W2922881551","https://openalex.org/W2927183570","https://openalex.org/W4236767152","https://openalex.org/W4281632075","https://openalex.org/W4379967447","https://openalex.org/W4389079291","https://openalex.org/W4391671363"],"related_works":["https://openalex.org/W4404181928","https://openalex.org/W4391671363","https://openalex.org/W4405508425","https://openalex.org/W4405508398","https://openalex.org/W4389079291","https://openalex.org/W4394599146","https://openalex.org/W4407362153","https://openalex.org/W3208364643","https://openalex.org/W6999682994","https://openalex.org/W4412500582"],"abstract_inverted_index":{"Trofinetide":[0,177],"is":[1,16,164,178,200,322],"the":[2,9,21,39,66,110,179,203,206,221,255,334,343,359,372],"first":[3,180],"drug":[4,61,226,239],"to":[5,19,36,56,72,167,175,235,246,342,349,393,396],"be":[6,252,394],"approved":[7,181],"for":[8,103,126,130,183],"treatment":[10,182],"of":[11,25,28,42,149,153,223,238,262,276,308,318,337,374,399],"Rett":[12,184,386],"syndrome.":[13],"Hepatic":[14],"impairment":[15,45,83,151,163],"not":[17,165],"expected":[18,166],"affect":[20],"pharmacokinetic":[22],"(PK)":[23],"profile":[24],"trofinetide":[26,47,58,97,250,288,309,351,367,378,400],"because":[27,152,323],"predominant":[29],"renal":[30],"excretion.":[31],"This":[32,49,158,321],"study":[33,50,159],"was":[34],"conducted":[35],"help":[37],"understand":[38],"potential":[40],"impact":[41],"any":[43,224,375],"hepatic":[44,82,137,150,162],"on":[46,173],"PK.":[48],"used":[51,242],"physiologically":[52],"based":[53],"PK":[54],"modeling":[55],"estimate":[57],"exposure":[59,174],"(maximum":[60],"concentration":[62,142],"and":[63,80,106,129,135,227,257,270,298,371,388],"area":[64],"under":[65],"concentration-time":[67],"curve":[68],"from":[69,202],"time":[70,265],"zero":[71],"infinity)":[73],"in":[74,155,208,231,254,266,290,294,310,353,366,369,377,380],"virtual":[75,89,114,267,271,295,300],"patients":[76,131,272],"with":[77,88,132,146,273,303,315,325,385],"mild,":[78,133],"moderate,":[79,134,280],"severe":[81,136],"(per":[84],"Child-Pugh":[85],"classification)":[86],"compared":[87],"healthy":[90,127,268,296],"subjects":[91,128,269,297],"following":[92],"a":[93,169,186,195,243,402],"12":[94,403],"g":[95,404],"oral":[96,405],"dose.":[98,406],"In":[99],"individual":[100],"deterministic":[101],"simulations":[102,108,284],"matched":[104],"individuals":[105,115],"stochastic":[107],"at":[109],"population":[111],"level":[112],"(100":[113],"simulated":[116],"per":[117],"population),":[118],"as":[119],"anticipated,":[120],"predicted":[121,140,287],"plasma":[122,258,291,381],"exposures":[123,143],"were":[124,292,312],"similar":[125,293],"impairment.":[138],"However,":[139],"blood":[141,256,311,331,338,355,361,370],"slightly":[144,313],"increased":[145],"increasing":[147,316],"severity":[148,317],"change":[154,376],"hematocrit":[156],"levels.":[157],"indicates":[160],"that":[161,190,286,383],"have":[168,328],"clinically":[170],"relevant":[171],"effect":[172],"trofinetide.":[176],"syndrome,":[185],"rare":[187],"genetic":[188],"condition":[189],"affects":[191],"brain":[192],"development.":[193],"When":[194],"person":[196],"takes":[197],"trofinetide,":[198],"most":[199],"removed":[201],"body":[204],"via":[205],"urine":[207],"its":[209],"unchanged":[210],"form":[211],"(no":[212],"chemical":[213],"alteration).":[214],"Regulatory":[215],"requirements":[216],"mean":[217],"researchers":[218],"must":[219],"confirm":[220],"safety":[222],"pharmaceutical":[225],"evaluate":[228],"whether":[229],"changes":[230],"liver":[232,277,304,319,326,389],"function":[233],"lead":[234],"harmful":[236,397],"levels":[237,289,307,368,379,398],"exposure.":[240],"Researchers":[241],"computer":[244],"model":[245],"predict":[247],"how":[248],"much":[249],"would":[251],"present":[253],"(the":[259],"liquid":[260,344],"portion":[261,336,345],"blood)":[263],"over":[264],"varying":[274],"degrees":[275],"disease":[278,327,390],"(mild,":[279],"or":[281],"severe).":[282],"Computer":[283],"showed":[285],"each":[299],"patient":[301],"group":[302],"disease.":[305,320],"Predicted":[306],"elevated":[314],"people":[324,384],"fewer":[329],"red":[330,360],"cells,":[332],"so":[333],"cell":[335],"becomes":[339],"smaller":[340],"relative":[341],"(plasma),":[346],"which":[347],"leads":[348],"higher":[350],"concentrations":[352],"whole":[354],"(trofinetide":[356],"minimally":[357],"enters":[358],"cell).":[362],"The":[363],"small":[364],"increase":[365],"absence":[373],"means":[382],"syndrome":[387],"are":[391],"unlikely":[392],"exposed":[395],"after":[401]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-06T00:00:00"}